2024 ASCO Direct Washington D.C.

Learn How to Claim Your Credit

 
 

Total Health's 2024 ASCO Direct™ Washington, DC Conference is an officially licensed ASCO Direct meeting. This Post ASCO Review showcases abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as an in-person conference only with on-demand access for registered attendees.

 

Accreditation Information | 7.25

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 
  • Amedco LLC designates this activity for a maximum of 7.25 ANCC contact hours.

  • Amedco LLC designates this live activity for a maximum of 7.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Amedco LLC designates this activity for a maximum of 7.25 knowledge-based CPE contact hours.

    NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.

  • Learner Notification

    Objectives - After Attending This Program You Should Be Able To

    1. Integrate new evidence into everyday clinical practice, thereby improving the quality of care being delivered to patients living with and beyond cancer.

    2. Implement practice changes in a variety of treatment options for solid tumors, including lung, breast, melanoma, colorectal, non-colorectal GI, and GU cancers.

    3. Stimulate innovative strategies for new and additional research related to treatment and prevention.

    Disclosure of Conflict of Interest

    The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)

    All individuals in a position to control the content of CE are listed below.

    Name Commercial Interest:Relationship

    Nagla Karmin, Regeneron, sanofi:Speakers Bureau Exelixis:Research Grant Site Principal Investigator Genentech, Astra Zeneca, Novo cure:Scientific/Medical Advisory Board Member

    Jeanny Aragon-Ching, Pfizer, EMD Serono, Astellas, Janssen, AVEO, AZD, Exelixis, Bayer:Consultant EMD Serono, BMS, Pfizer/Seagen, Astellas:Speakers Bureau

    Louise Connell, Intera:Consultant

    Nancy Dawson, Lantheus, SMPA, Merck, Janssen, Astellas, Pfizer, Exelexis, Baer, EMD SorenoAstra Zenecca, Eisai E:Speakers Bureau

    John Deeken, Merck, Biogene:Research Grant Site Principal Investigator

    Kieron Dunleavy, Astra Zeneca, Abbvie, ADCTherapeutics, Beigene, Bristol Myers Squibb, Amgen, Genentech, Janssen, Pharmacyclics, Incyte, ONO, Cellectar:Scientific/Medical Advisory Board Member

    Linda Fleisher NA

    Henry Fung NA

    Geoff Gibney, Merck, BMS, Iovance, Incyte, Immunocore, Replimune, Novartis, Lyell, Pfizer, Eisai :Consultant Immunocore:Speakers Bureau

    Hamza Hashmi, JANSSEN:Consultant

    Chul Kim, AstraZeneca, Novartis, Regeneron, Janssen, Genentech, Lyell, Daiichi Sankyo, Boehringer Ingelheim, Black Diamond Therapeutics:Research Grant Site Principal Investigator Gilead, Macrogenics:Research Grant Overall Principal Investigator Arcus, AstraZeneca, Daiichi Sankyo, Eisai, Regeneron, Sanofi, Takeda, J&J, Pinetree, Boehringer Ingelheim:Scientific/Medical Advisory Board Member

    Daniella Landau, NA

    Sami Mansfield NA

    John Marshall, AZ, Merck, Bayer, Taiho, Seagen, Pfizer:Consultant Caris, 2curex, OnDose:Scientific/Medical Advisory Board Member Indivumed:Employee

    Liza Marshall, NA

    Dalia Mobarek, NA

    Reyna Wilhelm NA

    Gustavo Rivero, NA

    Ravi Salgia, Alliance:Other Zai Lab (US) LLC, Intellisphere, LCC:Speakers Bureau Circle Pharma:Consultant Novelty Nobility:Scientific/Medical Advisory Board Member

    Jessica Tao MD

    Justin Kaiser, MD

 
 

How to Get Your Certificate

    1. Go to thc.cmecertificateonline.com

    2. 2. Click on the ASCO Washington DC 2024 link.

    3. 3. For ABIM MOC click on the ASCO Washington DC 2024 ABIM MOC link.

    4. 4. Evaluate the meeting.

    5. 5. Print, download, or save your certificate for your records.

    6. 6. If you lose your certificate, or need help, go to help.cmecertificateonline.com

 
 
Previous
Previous

2024 ASCO Direct Philadelphia

Next
Next

2024 Best of ASCO Memphis